Molecules & Empires

Molecules & Empires

Home
Notes
Archive
About

The Future Pharma Company Won't Look Like Today's Pfizer

The best AI in the world may not "crack" biology, but it can still change how a drug company is run.
READ THE LATEST
Will the Embryo-Editing Revolution Eventually Arrive the Way AI's Did?
The hype around designer babies, the actual science behind the headlines, and the embryo-selection market already taking shape.
 • Andrii Buvailo, PhD
What do the Origin of Life, a Hundred Billion Dollars, and a Viral Outbreak on a Cruise Ship Have in Common?
The murky yet promising future of the most programmable molecule in medicine.
 • Andrii Buvailo, PhD
Who Wins When Agents Come?
Autonomous AI systems are rewriting the economic patterns that organized modern society. They do it faster and messier than anyone could predict.
 • Andrii Buvailo, PhD
Can a Biohacker With AI Tools Do Pharma's Job?
The hype around a tech entrepreneur, his dying dog, and a cancer vaccine he designed using AI tools gets almost everything wrong. The thing it gets…
 • Andrii Buvailo, PhD
Gatekeepers of the New Baseline
GLP-1 drugs, longevity, and the real cost of controlling human metabolism
 • Andrii Buvailo, PhD
What Stood Out to Me in 2026 Breakthrough Technologies List by MIT Technology Review?
From embryo scoring and gene editing to studying AI systems, we don’t fully understand…
 • Andrii Buvailo, PhD
A Thought About Aging I Can’t Unsee
We are not one organism.
 • Andrii Buvailo, PhD
Molecules & Empires
Molecules & Empires
Notes on how scientific breakthroughs reshape industries, economies, and power.
Recommendations
Where Tech Meets Bio
Where Tech Meets Bio
BiopharmaTrend
Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI
Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI
Alex Zhavoronkov, PhD

Molecules & Empires

AboutArchiveRecommendationsSitemap
© 2026 Andrii Buvailo · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture